If you can’t join them for their Beyond the Bloodspot Summit tomorrow in DC, be sure to catch the available Livestream portion of this event hosted by Genetic Alliance.
The direct link to login into the Livestream is here (https://new.livestream.com/accounts/195545/Beyond-the-Bloodspot ), where you’ll also be able to follow the dialogue.
The event will include a day of discussion and thought-provoking sessions, which will look at the changing landscape of screening and what lessons can be learned from both emerging technologies and established population-based screening programs.
As we arrive to an age of next generation sequencing, a key question is upon us: how will this impact newborn screening as we know it? For 50 years– since the discovery of the filter paper method to screen for phenylketonuria (PKU) in 1962– newborn screening has undergone consistent, measurable advancements.
Over the last decade, advocacy organizations and individuals with children affected by rare conditions have become increasingly vocal about the need to expand research and the list of conditions on state newborn screening panels. As new technologies and research findings continue to transform newborn screening, ongoing public dialogue on issues inherent to the screening process is imperative.